GIM
TCRT icon

Goelzer Investment Management’s Alaunos Therapeutics TCRT Stock Holding History

Goelzer Investment Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-133
Closed -$87K – 197
2013
Q4 		$87K Buy
+133
New +$79.2K 0.02% 190

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BGA
Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goelzer Investment Management's TCRT Position: Q1 2014 in Review

Goelzer Investment Management sold out of Alaunos Therapeutics (TCRT) in Q1 2014, closing a stake of 133 shares — an estimated $87K sold.

Goelzer Investment Management first reported a position in TCRT in Q4 2013 and held it in 1 quarter. The position peaked at $87K in Q4 2013. 96 funds tracked by Wall St. Rank hold TCRT as of Q1 2014.

  • Goelzer Investment Management reported no remaining Alaunos Therapeutics position as of Q1 2014 after selling out during the quarter.
  • Goelzer Investment Management sold 133 Alaunos Therapeutics shares in Q1 2014, an estimated $87K.
  • Goelzer Investment Management first reported a position in Alaunos Therapeutics in Q4 2013 and held it in 1 quarter.
  • Goelzer Investment Management's Alaunos Therapeutics position peaked at $87K in Q4 2013.
  • 96 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2014.

Based on Goelzer Investment Management's 13F filing for Q1 2014, filed 25 Apr 2014.